What is RAD-140 (testolone)?
The short answer
RAD-140 is a lab-made compound that is studied in research on the same system as male hormones.
What it is
Non-steroidal compound that binds the androgen receptor in a selective way.
What people look into
Muscle and exercise
- 6 sources
- Status as of
- How we source
- Ellum doesn't sell peptides.
Get updates on RAD-140 (testolone)
What it is
- Type
- Selective androgen receptor modulator (SARM), non-steroidal
- Also known as
- vosilasarm
- How it works
- Non-steroidal compound that binds the androgen receptor in a selective way.
Regulatory status
Not FDA-approved How we label status
As of October 4, 2026, RAD-140 (testolone) is not FDA-approved for any use and is not on FDA's 503A bulks list.
- Federal (FDA)
- Not FDA-approved; FDA: SARMs 'cannot be legally marketed in the U.S. as a dietary supplement or drug'
- 503A compounding
- No category; not on 216.23 as of 2026-10-07 (as of October 7, 2026)
- WADA 2026
- S1.2 (named RAD140)
Timeline
Scroll sideways to see all columns.
Timeline table
| Date | What happened | Source |
|---|---|---|
| FDA debarment notice in the Federal Register lists RAD140 among drug ingredients imported in the conduct behind the underlying conviction. | Federal Register, event of February 14, 2022, on federalregister.gov | |
| FDA warning letter states that products marketed as SARMs, including testolone (RAD-140), are unapproved new drugs. | FDA, event of July 6, 2022, on fda.gov | |
| FDA warning letter states that products marketed as SARMs, including RAD-140 (testolone), are unapproved new drugs. | FDA (1 of 3), event of December 12, 2025, on fda.gov FDA (2 of 3), event of December 12, 2025, on fda.gov FDA (3 of 3), event of December 12, 2025, on fda.gov |
US enforcement actions
1 US enforcement action, in 2023.
Actions by US federal and state agencies whose documents name RAD-140 (testolone). Each row links to the government's own document.
Scroll sideways to see all columns.
US enforcement actions table
| Date | Agency | Action | Document |
|---|---|---|---|
| FDA | Warning letter | FDA document, warning letter, June 12, 2023, on fda.gov |
References
Sources as of October 4, 2026
- FDA: www.fda.gov/consumers/consumer-updates/fda-warns-use-selective-androgen-receptor-modulators-sarms-among-teens-young-adults
- FDA: www.fda.gov/food/dietary-supplements/information-select-dietary-supplement-ingredients-and-other-substances
- FDA warning letter, June 12, 2023
- FDA warning letter, December 12, 2025
- WADA: www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf
- eCFR: www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.23